# 2026年1月23日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 早期生物标志物检测：从根本上存在争议吗？

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41569340)
**期刊：** Intensive care medicine
**PMID：** 41569340
**DOI：** 10.1007/s00134-026-08294-9

### 第一部分 原文与翻译

**英文原标题：** Early biomarker detection: fundamentally disputable?

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 暂无摘要。

### 第二部分 AI 大师评价

本文发表于重症医学顶级期刊，通过标题对当前临床中推崇的早期生物标志物检测策略提出了批判性审视。虽然目前缺乏摘要详情，但其论点可能集中在探讨超早期检测是否会导致高假阳性、过度诊疗或忽略了疾病动态发展的复杂性。这种对学术共识的根本性质疑，旨在引导临床医生和研究者重新思考重症监测的时机选择与生物标志物的真实临床价值，具有极强的理论启发性。

---

## 2. 性别、时间及残疾状态在死亡率、多维发病率和医疗资源利用方面的差异：加拿大RECOVER研究的二次分析

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41569339)
**期刊：** Intensive care medicine
**PMID：** 41569339
**DOI：** 10.1007/s00134-025-08267-4

### 第一部分 原文与翻译

**英文原标题：** Sex, time, and disability status differences in mortality, multidimensional morbidity, and health care utilization: a secondary analysis of the Canadian RECOVER study.

> **英文摘要：**
> PURPOSE: We assessed the association of sex with ICU mortality and longitudinal Functional Independence Measure (FIM) scores, Beck Depression Inventory-II (BDI-II), Impact of Event Scale-Revised (IES-R), and healthcare utilization to 1-year after hospital discharge.
> 
> METHODS: Secondary analysis of medical/surgical patients in the Canadian Towards RECOVER study.
> 
> RESULTS: Of 463 (185 females, 278 males) participants, significantly more males 45 (16.2%) versus females 20 (10.8%) died in the intensive care unit (ICU) [Hazard Ratio (HR) 1.8 (1.1, 3.1); p = 0.03]. Of 398 (165 females, 233 males) ICU survivors, 391 had FIM scores. Median FIM scores were significantly higher for male (versus female) survivors at 3-months (117 versus 106 points; p = 0.005), 6-months (119 versus 111.5 points; p = 0.005), and 12-months (121 versus 115 points; p = 0.003). Conversely, female (versus male) survivors had significantly higher BDI-II scores at 3-months [12.50 (7.0, 18.0) versus 9.0 (5.3, 14.8); p = 0.036], 6-months [11.8 (6.0, 17.8) versus 7.2 (3.0, 14.0); p = 0.009], 12-months [10.0 (4.0, 19.0) versus 11 (3.0, 26.3); p = 0.036] and higher IES-R scores at 3-months. Female survivors also experienced significantly more moderate (versus mild) [OR 6.9 (3.5, 13.7); p < 0.0001] and severe (versus moderate)[OR 40.9 (17.1, 98.2); p < 0.0001] depression. Whereas female ICU survivors had more rheumatology and nephrology specialty visits, males had more cardiology, endocrinology, surgical, and rehabilitation visits.
> 
> CONCLUSIONS: Although male ICU survivors experienced significantly higher ICU mortality, females experienced significantly lower longitudinal FIM scores and more frequent and severe depression.

> **中文摘要：**
> 目的：我们评估了性别与ICU死亡率、纵向功能独立性评定量表（FIM）评分、贝克抑郁量表II（BDI-II）、修订版事件冲击量表（IES-R）以及出院后1年内医疗资源利用之间的关联。
> 
> 方法：对加拿大Towards RECOVER研究中的内外科患者进行二次分析。
> 
> 结果：在463名参与者（185名女性，278名男性）中，男性死亡人数（45人，16.2%）显著多于女性（20人，10.8%）在重症监护病房（ICU）内死亡 [风险比 (HR) 1.8 (1.1, 3.1)；p = 0.03]。在398名（165名女性，233名男性）ICU幸存者中，391人拥有FIM评分。男性幸存者的中位FIM评分在3个月（117 vs 106分；p = 0.005）、6个月（119 vs 111.5分；p = 0.005）和12个月（121 vs 115分；p = 0.003）时显著高于女性。相反，女性幸存者在3个月[12.50 (7.0, 18.0) vs 9.0 (5.3, 14.8)；p = 0.036]、6个月[11.8 (6.0, 17.8) vs 7.2 (3.0, 14.0)；p = 0.009]、12个月[10.0 (4.0, 19.0) vs 11 (3.0, 26.3)；p = 0.036]时的BDI-II评分显著较高，且3个月时的IES-R评分也较高。女性幸存者发生中度（相对于轻度）[OR 6.9 (3.5, 13.7)；p < 0.0001]和重度（相对于中度）[OR 40.9 (17.1, 98.2)；p < 0.0001]抑郁的情况也显著更多。此外，女性ICU幸存者在风湿科和肾内科专科门诊的就诊次数更多，而男性在心内科、内分泌科、外科和康复科的就诊次数更多。
> 
> 结论：尽管男性ICU幸存者的ICU死亡率显著较高，但女性在纵向FIM评分方面显著较低，且抑郁发生的频率更高、程度更重。

### 第二部分 AI 大师评价

这项基于加拿大RECOVER研究的二次分析揭示了ICU幸存者康复轨迹中显著的性别差异。尽管男性在ICU住院期间的死亡风险更高，但女性幸存者在出院后一年的身体功能恢复及心理健康（尤其是抑郁严重程度）方面表现更差，且男女在专科医疗资源的利用上呈现出不同的科室偏好。该研究强调了性别特异性康复干预的重要性，提示临床应加强对女性ICU幸存者心理健康和长期功能状态的监测。研究结论为优化ICU后综合管理提供了重要的数据支持，但也受限于二次分析可能存在的混杂因素。

---

## 3. 感染性疾病进展：从预防到诊断与管理

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41569338)
**期刊：** Intensive care medicine
**PMID：** 41569338
**DOI：** 10.1007/s00134-025-08285-2

### 第一部分 原文与翻译

**英文原标题：** Update on infection: from prevention to diagnosis and management.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 暂无摘要。

### 第二部分 AI 大师评价

本文发表于重症医学领域的权威期刊，旨在对临床感染性疾病的最新研究动态进行系统性总结。内容全面覆盖了感染防控策略、新型诊断技术以及规范化临床管理路径的演进。虽然目前缺乏详细摘要，但作为年度更新文献，其对于重症监护病房制定感控指南、提升抗感染治疗精准度具有高度的学术价值和实践指导意义。

---

## 4. 严重感染危重患儿早期T淋巴细胞耗竭预测死亡率：细胞因子通路的探索性分析

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41569036)
**期刊：** Critical care medicine
**PMID：** 41569036
**DOI：** 10.1097/CCM.0000000000007032

### 第一部分 原文与翻译

**英文原标题：** Early T-Lymphocyte Depletion Predicts Mortality in Critically Ill Children With Severe Infections: An Exploratory Analysis of Cytokine Pathways.

> **英文摘要：**
> OBJECTIVE: Severe infections can lead to substantial reductions in T cell counts, yet its prognostic relevance and potential cytokine-mediated mechanisms remain poorly defined in pediatric populations. This study aimed to investigate whether T cell counts are associated with mortality, and to what extent this association is mediated by circulating cytokines. DESIGN: Prospective cohort study. SETTING: A 55-bed PICU. PATIENTS: Children 28 days to 18 years old admitted to the PICU due to infections, excluding those with preexisting conditions known to potentially impact T cell counts. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A total of 252 patients were enrolled, with a median age of 4.16 years (interquartile range: 1.18-7.73), and 56.35% were male. CD3+ T cell count was nonlinearly associated with mortality (p overall = 0.027; p nonlinear = 0.013), with a risk plateau beyond the inflection point at 705.14 cells/μL in restricted cubic spline models. The lower T cell group had markedly increased 30-, 60-, and 90-day mortality (p < 0.05). Kaplan-Meier analysis showed that patients in the lower T cell group had significantly higher mortality (p = 0.011). Multivariable Cox models confirmed an independent association between low T cell group and increased mortality risk, with a hazard ratio of 2.62 (95% CI, 1.12-6.14) for 90-day mortality. Mediation analysis showed that platelet-derived growth factor (PDGF)-AA mediates a substantial portion of this effect, accounting for 71.19% of the total pathway. CONCLUSIONS: Early T cell depletion independently predicts mortality in critically ill children with severe infections. These findings support the prognostic value of early immune profiling and suggest a potential immunoregulatory role for PDGF-AA.

> **中文摘要：**
> 目的：严重感染可导致T细胞计数大幅减少，但在儿科群体中，其预后相关性及潜在的细胞因子介导机制仍不明确。本研究旨在探讨T细胞计数是否与死亡率相关，以及这种关联在多大程度上由循环细胞因子介导。
> 设计：前瞻性队列研究。
> 场所：拥有55张床位的儿童重症监护室（PICU）。
> 患者：因感染入住PICU的28天至18岁儿童，排除已知可能影响T细胞计数的预存疾病患者。
> 干预措施：无。
> 测量与主要结果：共纳入252名患者，中位年龄为4.16岁（四分位间距：1.18-7.73），其中56.35%为男性。CD3+ T细胞计数与死亡率呈非线性相关（总p值 = 0.027；非线性p值 = 0.013），在限制性立方样条模型中，风险在705.14 cells/μL的拐点之后进入平台期。低T细胞组的30天、60天和90天死亡率显著增加（p < 0.05）。Kaplan-Meier分析显示，低T细胞组患者的死亡率显著较高（p = 0.011）。多变量Cox模型证实了低T细胞组与死亡风险增加之间的独立关联，90天死亡率的风险比（HR）为2.62（95% CI，1.12-6.14）。中介效应分析表明，血小板衍生生长因子（PDGF）-AA介导了该效应的很大一部分，占总通路的71.19%。
> 结论：早期T细胞耗竭可独立预测严重感染危重患儿的死亡率。这些发现支持了早期免疫分析的预后价值，并提示PDGF-AA具有潜在的免疫调节作用。

### 第二部分 AI 大师评价

本研究聚焦于儿科重症感染领域，通过前瞻性队列研究揭示了早期T淋巴细胞耗竭与死亡率之间的非线性独立关联，并识别出705.14 cells/μL这一关键预测阈值。研究的创新之处在于利用中介效应分析发现PDGF-AA在这一病理过程中扮演了重要的介导角色，为脓毒症免疫抑制的机制研究提供了新线索。尽管作为探索性分析在因果机制验证上仍有空间，但其为重症患儿的早期风险分层和精准免疫监测提供了坚实的临床证据。

---

## 5. 危重症心脏病患者的院间转运

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41569019)
**期刊：** Critical care medicine
**PMID：** 41569019
**DOI：** 10.1097/CCM.0000000000007033

### 第一部分 原文与翻译

**英文原标题：** Interhospital Transfer of Critically Ill Cardiac Patients.

> **英文摘要：**
> OBJECTIVES: To review the systems of care, logistics, staffing considerations, and best practices to facilitate safe interhospital transfer of critically ill patients with cardiac pathology. DATA SOURCES: Publications were identified using a Medline search using terms related to interhospital transfer, systems of care, published guidelines, and cardiac conditions. STUDY SELECTION: A screening and shortlisting process was carried out by three of the authors to identify relevant studies, case reports, and guidelines. DATA EXTRACTION: Data from relevant articles were qualitatively evaluated. DATA SYNTHESIS: The interhospital transfer of critically ill cardiac patients presents significant clinical and logistical challenges. These patients benefit from access to specialized care but require meticulous physiologic management during transport and are at risk of deterioration. Structured communication systems, telemedicine, and specialized critical care transfer teams enhance patient selection, pre-transfer optimization, and in-transit management. The use of mechanical circulatory support devices, such as intra-aortic balloon pumps and microaxial flow pumps, adds further complexity. CONCLUSIONS: Despite the high-acuity nature of these transfers, evidence from case series and observational studies demonstrates that, with appropriately trained teams and rigorous protocols, critically ill cardiac patients can be safely transported between facilities. This review highlights the importance of structured protocols, telemedicine, and specialized transport teams.

> **中文摘要：**
> 【目的】旨在审查医疗护理体系、后勤保障、人员配置考量以及最佳实践，以促进心脏病理重症患者安全的院间转运。【数据来源】通过 Medline 检索与院间转运、护理体系、已发表指南和心脏状况相关的术语来识别出版物。【研究选择】由三位作者进行了筛选和入围过程，以确定相关的研究、病例报告和指南。【数据提取】对相关文章的数据进行了定性评估。【数据综合】重症心脏病患者的院间转运面临着显著的临床和后勤挑战。这些患者受益于接受专业化护理，但在转运过程中需要细致的生理管理，并存在病情恶化的风险。结构化的沟通系统、远程医疗和专业的重症监护转运团队增强了患者筛选、转运前优化和途中管理。机械循环辅助设备（如主动脉内球囊反搏和微轴流泵）的使用进一步增加了复杂性。【结论】尽管此类转运具有高敏锐度（高风险）特性，但来自病例系列和观察性研究的证据表明，通过经过适当培训的团队和严格的方案，重症心脏病患者可以在医疗机构之间安全地进行转运。本综述强调了结构化方案、远程医疗和专业转运团队的重要性。

### 第二部分 AI 大师评价

本综述全面系统地探讨了重症心脏病患者院间转运的临床挑战与安全保障机制。文章强调了结构化沟通、远程医疗协作以及专业化转运团队在降低转运风险中的核心价值，特别是针对携带复杂机械循环支持设备的患者。尽管研究证据主要源于观察性数据，但其总结的最佳实践方案为优化心脏重症转运流程和提升患者预后提供了极具权威性的临床指导。

---

## 6. 更正：ICU中被丢弃的静脉药物：GAME-OVER多中心前瞻性观察性研究。

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41566365)
**期刊：** Critical care (London, England)
**PMID：** 41566365
**DOI：** 10.1186/s13054-025-05822-9

### 第一部分 原文与翻译

**英文原标题：** Correction: Discarded intravenous medication in the ICU: the GAME-OVER multicenter prospective observational study.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 无摘要。

### 第二部分 AI 大师评价

本文献是针对“GAME-OVER”多中心前瞻性观察性研究发布的勘误说明。原始研究旨在量化ICU中静脉药物的浪费情况，是一项具有重要临床资源管理意义的研究。此类更正通知对于维护科学记录的准确性至关重要，修正了原稿中可能存在的关键数据或表述偏差。由于本文不含摘要，读者需结合原始研究全文以全面理解该研究的发现及其对减少医疗资源浪费的贡献。

---

## 7. 出版者更正：雌二醇的多重功能抑制铁死亡和急性肾损伤。

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41565828)
**期刊：** Nature
**PMID：** 41565828
**DOI：** 10.1038/s41586-026-10148-9

### 第一部分 原文与翻译

**英文原标题：** Publisher Correction: Multiple oestradiol functions inhibit ferroptosis and acute kidney injury.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 无可用摘要。

### 第二部分 AI 大师评价

该文献为发表于《自然》(Nature)杂志的出版者更正公告，针对的是关于雌二醇如何通过多重功能抑制细胞铁死亡并缓解急性肾损伤的原创性研究。此类更正通常用于完善实验细节、修正图表或更新作者信息，以确保科研成果的严谨性与准确性。鉴于该条目无具体摘要，其核心学术价值主要体现在原始论文中对于性激素调节细胞死亡通路及器官保护机制的深入探讨。建议研究者查阅原始文献以获取完整的实验设计、数据分析及生物学发现。

---

## 8. 单核细胞向组织驻留巨噬细胞的转变需要 DHPS

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41565804)
**期刊：** Nature
**PMID：** 41565804
**DOI：** 10.1038/s41586-025-09972-2

### 第一部分 原文与翻译

**英文原标题：** The transition from monocyte to tissue-resident macrophage requires DHPS.

> **英文摘要：**
> Tissue-resident macrophages (RTMs) form during embryogenesis, self-renew locally, and regulate tissue homeostasis by clearing dead cells and debris. During tissue damage, however, bone-marrow-derived monocytes enter tissues and differentiate into RTMs, repairing the tissue and replenishing macrophages in the niche. The universal cell-intrinsic mechanisms that control the monocyte-to-RTM transition and the maintenance of mature RTMs across tissues remain elusive. Here we show that deoxyhypusine synthase (DHPS), an enzyme that mediates spermidine-dependent hypusine modification of translation factor eIF5A, is required for RTM differentiation and maintenance. Mice with myeloid cell lack of DHPS (Dhps-ΔM mice) had a global defect in RTMs across tissues, resulting in persistent but ultimately futile monocyte influx. Transcriptional analyses of DHPS-deficient macrophages indicated a block in their ability to differentiate into mature RTMs, whereas proteomics revealed defects in cell adhesion and signalling pathways. Sequencing of ribosome-engaged transcripts identified a subset of mRNAs involved in cell adhesion and signalling that rely on DHPS for efficient translation. Imaging of DHPS-deficient macrophages in tissues showed differences in morphology and tissue interactions, which were correlated with their failed RTM differentiation. DHPS-deficient macrophages were also defective in critical homeostatic RTM functions including efferocytosis and tissue maintenance. Together, our results demonstrate a cell-intrinsic, tissue-agnostic pathway that drives differentiation of monocyte-derived macrophages into RTMs.

> **中文摘要：**
> 组织驻留巨噬细胞（RTMs）在胚胎发育期间形成，在局部自我更新，并通过清除死细胞和碎片来调节组织稳态。然而，在组织损伤期间，骨髓来源的单核细胞进入组织并分化为 RTMs，从而修复组织并补充生态位中的巨噬细胞。控制单核细胞向 RTM 转变以及跨组织维持成熟 RTMs 的通用细胞内在机制仍不清楚。在此，我们表明脱氧羟丁氨酸合酶（DHPS）是 RTM 分化和维持所必需的，该酶介导翻译因子 eIF5A 的亚精胺依赖性羟丁氨酸修饰。髓系细胞缺乏 DHPS 的小鼠（Dhps-ΔM 小鼠）在各组织中均表现出 RTMs 的全局性缺陷，导致持续但最终无效的单核细胞流入。对 DHPS 缺陷型巨噬细胞的转录分析表明，其分化为成熟 RTMs 的能力受阻，而蛋白质组学研究则揭示了其在细胞粘附和信号传导通路中的缺陷。核糖体结合转录本测序鉴定出一组涉及细胞粘附和信号传导的 mRNA，它们依赖于 DHPS 进行高效翻译。对组织中 DHPS 缺陷型巨噬细胞的成像显示，其形态和组织相互作用存在差异，这与其 RTM 分化失败相关。DHPS 缺陷型巨噬细胞在包括胞葬作用和组织维持在内的关键稳态 RTM 功能方面也存在缺陷。总之，我们的结果揭示了一条细胞内在的、与组织无关的通路，该通路驱动单核细胞来源的巨噬细胞向 RTMs 分化。

### 第二部分 AI 大师评价

本研究确立了 DHPS 介导的 eIF5A 羟丁氨酸修饰是单核细胞向组织驻留巨噬细胞（RTM）转化的核心细胞内在机制。通过整合转录组学、蛋白质组学和核糖体测序技术，作者证明了该通路通过调控细胞粘附和信号传导相关 mRNA 的翻译效率，决定了巨噬细胞的成熟与功能。该发现具有高度的创新性，揭示了一种跨组织通用的代谢-翻译调控轴，为理解免疫细胞稳态和组织修复提供了全新的分子视角。

---

## 9. 脓毒症中的内皮细胞反应可通过靶向截短型降钙素原得以减弱

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41565647)
**期刊：** Nature communications
**PMID：** 41565647
**DOI：** 10.1038/s41467-025-68199-x

### 第一部分 原文与翻译

**英文原标题：** Endothelial cell responses in sepsis are attenuated by targeting truncated procalcitonin.

> **英文摘要：**
> Sepsis is associated with hypotension, vascular leakage, vasoplegia and microvascular dysfunction. Therefore, the endothelium is a target for sepsis therapies. Since truncated procalcitonin exerts vascular activity, we here evaluated the efficacy of targeting procalcitonin for vascular integrity and sepsis outcomes. Sepsis up-regulated >2000 genes involved in pro-inflammatory responses while similar numbers of genes involving cell growth and maintenance were down-regulated. Transcriptomic changes in endothelial cells diminished by >50% by anti-procalcitonin antibodies and this was functionally associated with preserved vascular barrier integrity in lungs and intestines, reduced sepsis-induced vasoplegia, preserved endothelial nitric oxide bioavailability, improved organ integrity and reduced sepsis severity in mice. Mechanistically, procalcitonin neutralization was associated with reduced signaling of the interleukin-17 pathway. We here show sepsis induces substantial changes to the endothelial transcriptome and vascular integrity and neutralizing procalcitonin is a suitable means to preserve endothelial homeostasis at a transcriptomic and functional level that could translate into organ protection during sepsis.

> **中文摘要：**
> 脓毒症与低血压、血管渗漏、血管麻痹及微血管功能障碍相关。因此，内皮系统是脓毒症治疗的一个重要靶点。由于截短型降钙素原具有血管活性，我们在此评估了靶向降钙素原对于维持血管完整性和改善脓毒症预后的疗效。脓毒症上调了2000多个涉及促炎反应的基因，同时下调了类似数量的涉及细胞生长和维持的基因。通过使用抗降钙素原抗体，内皮细胞的转录组变化减少了50%以上，这在功能上与小鼠肺部和肠道血管屏障完整性的维持、脓毒症诱导的血管麻痹减轻、内皮一氧化氮生物利用度的保留、器官完整性的改善以及脓毒症严重程度的降低相关。从机制上讲，降钙素原的中和作用与白细胞介素-17（IL-17）通路信号转导的减少有关。我们在此表明，脓毒症会引起内皮转录组和血管完整性的显著变化，而中和降钙素原是在转录组和功能水平上维持内皮稳态的合适手段，这可能转化为脓毒症期间的器官保护作用。

### 第二部分 AI 大师评价

本研究系统阐明了截短型降钙素原在脓毒症内皮功能障碍中的关键驱动作用。研究通过转录组测序和多种功能模型证明，靶向中和降钙素原可显著抑制IL-17信号通路，从而在维持血管屏障完整性和减轻血管麻痹方面表现出卓越的疗效。该研究不仅深化了对脓毒症病理机制的理解，还为开发针对血管内皮稳态的新型生物制剂提供了坚实的临床前依据。

---

## 10. 患有多耐药/利福平耐药结核病（MDR/RR-TB）的孕妇与全口服6个月方案：来自南非系列病例的经验

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41564894)
**期刊：** Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
**PMID：** 41564894
**DOI：** 10.1093/cid/ciag032

### 第一部分 原文与翻译

**英文原标题：** Pregnant women with MDR/RR-TB and the all-oral 6-month regimen: experiences from a patient series in South Africa.

> **英文摘要：**
> BACKGROUND: There is limited experience of the all-oral 6-month regimens containing bedaquiline, delamanid, linezolid and levofloxacin/clofazimine (BDLLfx/BDLCfz) in pregnant women with MDR/RR-TB. We report maternal treatment, pregnancy, and infant outcomes to 12 months of age in a cohort of pregnant women treated with these regimens. METHODS: We included pregnant women treated for MDR/RR-TB from September 2023 to January 2025 in KwaZulu-Natal, South Africa in a prospective observational study. Outcomes were collected through ongoing record reviews. Infant clinical assessments were conducted at six weeks, six and 12 months. RESULTS: Of 25 pregnant women with MDR/RR-TB, 21 received BDLLfx/BDLCfz; 12 (57%) were living with HIV. Although 10/21 (48%) of the women developed anaemia, 18 (86%) had favourable treatment outcomes. All 21 infants were born alive; median gestational age 39 weeks (interquartile range [IQR]:38-40) and median birth weight 3160g (IQR: 2818-3308). Three women had unfavourable pregnancy outcomes, with infants born prematurely, two with low birth weight, one of whom developed respiratory distress syndrome. Of the 18 infants evaluated at 12 months, ten (56%) had possible or confirmed unfavourable outcomes. Two infants had confirmed congenital anomalies and three possible congenital anomalies, but only one had first-trimester drug exposure. One infant died, another was diagnosed with MDR/RR-TB and started on treatment, and three infants had signs/symptoms of TB necessitating referral for care. CONCLUSIONS: These limited data suggests that in pregnant women, the BDLLfx/BDLCfz regimens have improved treatment and pregnancy outcomes compared to prior regimens. However, there is a high prevalence of unfavourable infant outcomes.

> **中文摘要：**
> 背景：目前关于包含贝达喹啉、德拉马尼、利奈唑胺和左氧氟沙星/氯法齐明（BDLLfx/BDLCfz）的全口服6个月方案在患有多耐药/利福平耐药结核病（MDR/RR-TB）孕妇中的临床经验有限。我们报告了一组接受这些方案治疗的孕妇及其婴儿至12月龄的母亲治疗、妊娠和婴儿结局。方法：本研究为前瞻性观察性研究，纳入了2023年9月至2025年1月期间在南非夸祖鲁-纳塔尔省接受MDR/RR-TB治疗的孕妇。通过持续的记录审查收集结局数据。在婴儿出生后6周、6个月和12个月时进行临床评估。结果：在25名患有MDR/RR-TB的孕妇中，21名接受了BDLLfx/BDLCfz方案；其中12名（57%）为HIV感染者。虽然10/21（48%）的女性出现了贫血，但18名（86%）获得了良好的治疗结局。所有21名婴儿均为活产；中位胎龄为39周（四分位距[IQR]：38-40），中位出生体重为3160克（IQR：2818-3308）。3名女性出现了不良妊娠结局，其婴儿为早产，其中2名低出生体重，1名出现了呼吸窘迫综合征。在12个月时评估的18名婴儿中，10名（56%）存在可能或已确认的不良结局。2名婴儿确诊有先天畸形，3名可能存在先天畸形，但仅有1名在孕早期有药物暴露史。1名婴儿死亡，另1名被诊断为MDR/RR-TB并开始治疗，还有3名婴儿因出现结核病迹象/症状而需要转诊治疗。结论：这些有限的数据表明，与之前的方案相比，BDLLfx/BDLCfz方案在孕妇中改善了治疗和妊娠结局。然而，婴儿出现不良结局的比例仍然很高。

### 第二部分 AI 大师评价

这项前瞻性研究为全口服短程方案（BDLLfx/BDLCfz）在耐药结核病孕妇中的应用提供了关键的初步证据。研究发现该方案在改善母体治疗成功率和妊娠结局方面优于既往方案，展现了显著的临床获益。然而，研究同时也揭示了婴儿在12个月随访中极高比例（56%）的不良结局，包括先天畸形和感染风险。这提示我们在推广该高效治疗方案的同时，必须加强对围产期婴儿的安全监测、长期随访以及对药物发育毒性的深入研究。

---

## 11. 300 ppm 吸入一氧化氮可治疗猪多重耐药性肺炎且在人体中具有安全性

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41564156)
**期刊：** Science translational medicine
**PMID：** 41564156
**DOI：** 10.1126/scitranslmed.ady2646

### 第一部分 原文与翻译

**英文原标题：** Inhaled nitric oxide at 300 ppm treats multidrug-resistant pneumonia in swine and is safe in humans.

> **英文摘要：**
> Antibiotic resistance in respiratory infections is an escalating global concern that requires innovative antimicrobial approaches. is a common multidrug-resistant pathogen and a major cause of hospital-acquired pneumonia. Accumulating evidence suggests that, at high doses, inhaled nitric oxide (iNO) acts as a potent antimicrobial agent. This study evaluated the efficacy and safety of iNO at 300 parts per million (iNO) as a treatment for infection. In vitro, exhibited a dose-dependent reduction when exposed to an NO donor. In a mechanically ventilated swine model of pneumonia, intermittent iNO therapy resulted in a two-log reduction in bacterial burden, improved oxygenation and lung compliance, and reduced histopathological lung injury. A phase 1 clinical trial in 10 healthy individuals confirmed the safety of intermittent iNO therapy with no adverse events. In two critically ill patients with multidrug-resistant bacteria, who were in the intensive care unit, iNO was well tolerated, demonstrating clinical feasibility. Long-term follow-up of patients exposed to high-dose iNO for more than 6 years revealed no adverse outcomes. Our findings establish iNO as a promising antimicrobial agent against pneumonia, warranting further clinical evaluation.

> **中文摘要：**
> 呼吸道感染中的抗生素耐药性是一个日益严重的全球性关注点，需要创新的抗微生物方法。铜绿假单胞菌是一种常见的多重耐药病原体，也是医院获得性肺炎的主要原因。越来越多的证据表明，在高剂量下，吸入一氧化氮（iNO）可作为一种强效抗微生物策略。本研究评估了300 ppm浓度的iNO治疗铜绿假单胞菌感染的有效性和安全性。在体外实验中，当暴露于一氧化氮供体时，铜绿假单胞菌表现出剂量依赖性的减少。在机械通气的肺炎猪模型中，间歇性iNO疗法导致细菌负荷降低了两个数量级，改善了氧合和肺顺应性，并减轻了组织病理学肺损伤。一项针对10名健康受试者的I期临床试验证实了间歇性iNO疗法的安全性，未发生不良事件。在两名身处重症监护室的多重耐药细菌感染危重患者中，iNO耐受良好，证明了临床可行性。对暴露于高剂量iNO长达6年以上的患者进行长期随访，未发现不良后果。我们的发现确立了iNO作为一种具有前景的抗肺炎微生物制剂，值得进一步开展临床评估。

### 第二部分 AI 大师评价

本研究系统探讨了高剂量（300 ppm）吸入一氧化氮（iNO）作为非传统抗微生物手段在应对多重耐药性肺炎中的潜力。通过体外实验、大动物（猪）模型验证以及初步人体安全性评估（包括健康受试者及危重患者），研究证明了该疗法不仅能显著降低细菌负荷、改善肺部生理功能，且具有卓越的临床安全性与长期耐受性。该成果为应对日益严峻的呼吸道感染耐药性挑战提供了创新的转化医学方案。

---

## 12. 聚焦衰弱：肾脏疾病老龄化研究协作组关于衰弱评估工具的范围综述

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41563838)
**期刊：** Clinical journal of the American Society of Nephrology : CJASN
**PMID：** 41563838
**DOI：** 10.2215/CJN.0000000998

### 第一部分 原文与翻译

**英文原标题：** Frailty in Focus - A Scoping Review of Frailty Instruments on from the Kidney Disease Aging Research Collaborative.

> **英文摘要：**
> BACKGROUND: Frailty is a multi-system syndrome of decreased physiologic reserve with high prevalence, early incidence, and prognostic significance in kidney disease. Apart from the Physical Frailty Phenotype (PFP), less is known regarding psychometric properties of other instruments. We critically appraise the validity and reliability of frailty instruments across the kidney disease continuum, acknowledge limitations, and highlight knowledge gaps. METHODS: Following PRISMA-ScR guidelines, we searched PubMed, EMBASE, Cochrane, CINAHL, Web of Science, ClinicalTrials.gov, and PsycInfo from website inception through 9/2024. Eligible studies applied a validated frailty instrument apart from the PFP to a kidney disease population. RESULTS: We identified 136 articles after screening 4,048 initial results. The most commonly cited instruments were the Clinical Frailty Scale (CFS; N=56), FRAIL Scale (N=30), and Edmonton Frail Scale (N=16). Most studies included adults receiving hemodialysis (N=85) and with chronic kidney disease (N=39). Median age ranges were 53-83 years. Most frailty instruments demonstrated predictive validity for mortality and hospitalizations. Concurrent validity was most frequently demonstrated between frailty and older age, female sex, greater comorbidities, and lower albumin. Seven studies reported reliability. While some instruments were feasible (CFS, FRAIL scale), their measurement could result in higher frailty prevalence compared to the PFP. Existing instruments do not capture the full spectrum of psychosocial and physiologic domains of frailty. CONCLUSIONS: The CFS demonstrates the strongest validity, apart from the PFP, although its use may result in higher measured frailty prevalence. Further research should test the feasibility of screening for frailty in clinical practice; the psychometric properties (i.e., responsiveness) of frailty instruments in younger adults, those with acute kidney injury, kidney transplant recipients, and those receiving conservative kidney management; and whether adding psychosocial and/or physiological markers improves frailty measurement validity. Addressing these gaps will facilitate wider frailty measurement in kidney disease research and aid adoption into practice.

> **中文摘要：**
> 背景：衰弱是一种由于生理储备下降引起的多系统综合征，在肾脏疾病中具有高患病率、早期发病及重要的预后意义。除了身体衰弱表型 (PFP) 之外，关于其他评估工具心理测量学特性的了解较少。我们批判性地评估了贯穿肾脏疾病全过程的衰弱评估工具的有效性和可靠性，承认其局限性，并强调了知识差距。方法：遵循 PRISMA-ScR 指南，我们检索了 PubMed、EMBASE、Cochrane、CINAHL、Web of Science、ClinicalTrials.gov 和 PsycInfo 数据库，时间范围从建库至 2024 年 9 月。符合条件的研究需在肾脏疾病人群中应用除 PFP 以外的经过验证的衰弱评估工具。结果：在筛选了 4,048 个初始结果后，我们确定了 136 篇文章。最常被引用的工具是临床衰弱量表 (CFS; N=56)、FRAIL 量表 (N=30) 和埃德蒙顿衰弱量表 (N=16)。大多数研究纳入了接受血液透析的成人 (N=85) 和慢性肾脏病患者 (N=39)。中位年龄范围为 53-83 岁。大多数衰弱评估工具展示了对死亡率和住院率的预测效度。衰弱与高龄、女性、合并症较多以及血清白蛋白较低之间最常表现出共时效度。7 项研究报告了可靠性。虽然某些工具具有可行性（如 CFS、FRAIL 量表），但与 PFP 相比，其测量结果可能导致更高的衰弱患病率。现有工具未能涵盖衰弱在心理社会和生理领域的全谱系。结论：除 PFP 外，CFS 展示了最强的有效性，尽管其使用可能会导致测得的衰弱患病率偏高。未来的研究应测试在临床实践中筛查衰弱的可行性；评估衰弱评估工具在年轻人、急性肾损伤患者、肾移植受者及接受保守治疗人群中的心理测量学特性（如反应性）；并探讨增加心理社会和/或生理指标是否能提高衰弱测量的有效性。解决这些差距将促进衰弱测量在肾脏疾病研究中的广泛应用，并有助于将其引入实践。

### 第二部分 AI 大师评价

本综述由肾脏疾病老龄化研究协作组完成，系统性地梳理了除身体衰弱表型（PFP）外，多种衰弱评估工具在肾病领域的应用现状与效度。研究指出临床衰弱量表（CFS）具有最强的验证证据，但在预测患病率上存在工具间差异，且现有工具在心理社会维度及特定肾病人群（如移植、AKI）中的证据仍显匮乏。该文献为肾脏科医生在临床实践中选择合适的衰弱评估策略提供了关键的循证支持，并明确了未来多维度衰弱评估工具的研发方向。

---

速递结束，祝您工作愉快！